Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Clinical trial NCT00335829 · COMPLETED
Trial details
- NCT number
- NCT00335829
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2011-02-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.